Liam Dann: $5.4b for Infratil? Tell them they're dreamin'
The big Aussie bid for Infratil is opportunistic and undervalued and should be rejected.
AdvertisementAdvertise with NZME.
Latest fromMarkets
Market close: NZ stocks a stone's throw away from record
NZ shares ended firmly, driven mostly by a strong performance from Meridian.
Market close: Sharemarket slips, Vista Group rises on purchase
The New Zealand sharemarket closed the week flat.
Jarden Brief: Trump's China moves set to make life difficult for Biden
Jarden's daily update on the latest market moves and shakes.
Import costs soar as global supply chain buckles under strain
Shipping rates have gone up 400 per cent since July, says freight sector.
Market close: 'Humpty Dumpty' F&P Healthcare has another great fall
Fisher and Paykel has a fall, picks itself up again, only to have another great fall.
Market Watch: Post-Covid boom could see interest rates rise sooner
Shares surged in November on vaccine news, does that mean interest rates will rise sooner?
Jarden Brief: Vaccine stocks rise as UK approves rollout
Jarden's daily update on the latest market moves and shakes.
Market close: Meridian hits new high, a2 Milk continues its slide
The New Zealand sharemarket slid late, closing down 1.22 points or 0.01 per cent.
Jarden Brief: US indices continue to hit record highs
Jarden's daily update on the latest market moves and shakes.
Lower mortgage rates before Christmas?
The Reserve Bank's funding for lending programme kicks off next week.
Market close: Kiwi Property biggest mover as sharemarket slips
The New Zealand sharemarket took a breather from its recent lofty gains.
Jarden Brief: The Chinese company Trump plans to blacklist
Jarden's daily update on the latest market moves and shakes.
Market close: NZX hits new high to cap off impressive month
The New Zealand sharemarket has risen more than 5 per cent in an impressive November.
The US-China relationship under Joe Biden
The President-elect has work to do to unwind Donald Trump's legacy of protectionism.
Mary Holm: Share markets choc-full of temptation
Resist the urge to pick the sweetest deals — even the full-time investors can't do it.
Market close: NZ shares edge ahead, F&P Healthcare rebounds
The S&P/NZX 50 Index edged ahead in a quiet end to the week.
Jarden Brief: TikTok owner running out of time to sell or face US ban
Jarden's daily update on the latest market moves and shakes.
What happens to markets, post Covid?
Investors are pondering what markets will look like, post Covid-19.
Market close: NZ shares fall as Kiwi dollar weighs on market
The fast-rising NZ dollar began weighing on the New Zealand sharemarket.
Even in a pandemic, the billionaires are winning
New York Times: In the worst economic crisis since the 1930s, billionaires' wealth grew.
Jarden Brief: US market drops back down from record level
Jarden's daily update on the latest market moves and shakes.
Market close: Records order of the day, Mainfreight hits $61
The buoyant New Zealand sharemarket made another healthy gain on strong turnover.
Jarden Brief: All eyes on Financial Stability report today
Jarden's daily update on the latest moves and shakes on the market.
The flying kiwi: Why the NZ dollar keeps going up
The New Zealand dollar keeps breaking higher, despite Covid-19.
Market close: F&P Healthcare surges, Harmoney slips further
The New Zealand sharemarket had another positive day.
Jarden Brief: Trump eyes restrictions on 89 Chinese companies
Jarden's daily update on the latest market moves and shakes.
Market close: Mainfreight's next stop, $62?
Energy stocks and other heavyweights made useful gains.
Liam Dann: What Guns N' Roses can tell us about the end of the pandemic
Vaccine news hasn't prompted the celebrations it might have but GNR are ready to party.
Market close: NZX takes late dive, Ryman and F&P Healthcare fall
The New Zealand sharemarket fell nearly one per cent.
Jarden Brief: How Covid-19 surge is affecting US markets
Jarden's daily update on the latest market moves and shakes.
Market close: NZX falls for second straight day, Harmoney's slow start
The S&P/NZX 50 Index was down 0.39 per cent.
Harmoney fails to fire on ASX listing
Harmoney opted for a primary listing on the ASX, with a "foreign exempt" listing on NZX.
Vocus to float its NZ business, which includes Orcon and Slingshot
Who could be in the frame if the IPO is headed-off by a trade sale.